NPI: 1740553932 · SAUK CENTRE, MN 56378 · Critical Access Hospital · NPI assigned 02/17/2012
Authorized official BLAIR, MICHAEL controls 20+ related entities in our dataset. Read more
| Authorized Official | BLAIR, MICHAEL (SR. VICE PRESIDENT AND CFO) |
| NPI Enumeration Date | 02/17/2012 |
Other providers sharing the same authorized official: BLAIR, MICHAEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| ST. CLOUD HOSPITAL | SAINT CLOUD | MN | $53.43M |
| CENTRACARE CLINIC | ST CLOUD | MN | $20.93M |
| CENTRACARE CLINIC | ST CLOUD | MN | $19.28M |
| CENTRACARE HEALTH SYSTEM | BIG LAKE | MN | $12.82M |
| CARRIS HEALTH LLC | WILLMAR | MN | $12.39M |
| CENTRACARE HEALTH SYSTEMS | SAINT CLOUD | MN | $9.41M |
| CENTRACARE HEALTH SYSTEM | SAINT CLOUD | MN | $9.06M |
| CARRIS HEALTH LLC | WILLMAR | MN | $8.27M |
| CENTRACARE CLINIC | SAINT CLOUD | MN | $6.96M |
| CENTRACARE HEALTH SYSTEM - LONG PRAIRIE | LONG PRAIRIE | MN | $6.86M |
| CENTRACARE HEALTH SYSTEM-NR LLC | MONTICELLO | MN | $6.73M |
| CENTRACARE CLINIC | SARTELL | MN | $6.11M |
| ST. CLOUD HOSPITAL | SAINT CLOUD | MN | $5.16M |
| CARRIS HEALTH - REDWOOD LLC | REDWOOD FALLS | MN | $4.74M |
| ST. CLOUD HOSPITAL | ST CLOUD | MN | $4.44M |
| CENTRACARE HEALTH SYSTEM - SAUK CENTRE | SAUK CENTRE | MN | $4.19M |
| CENTRACARE HEALTH SYSTEM - MELROSE | MELROSE | MN | $4.05M |
| CENTRACARE CLINIC | SAINT CLOUD | MN | $3.58M |
| CENTRACARE CLINIC | SAINT CLOUD | MN | $2.83M |
| CARRIS HEALTH, LLC | WILLMAR | MN | $2.82M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 329 | $2K |
| 2019 | 239 | $7K |
| 2020 | 761 | $33K |
| 2021 | 781 | $43K |
| 2022 | 1,235 | $78K |
| 2023 | 926 | $77K |
| 2024 | 343 | $40K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 750 | 568 | $121K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,031 | 488 | $62K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 220 | 208 | $43K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 401 | 391 | $15K |
| 36415 | Collection of venous blood by venipuncture | 1,210 | 1,064 | $13K |
| 80048 | Basic metabolic panel (calcium, ionized) | 505 | 437 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 178 | 161 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 195 | 89 | $3K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 15 | 15 | $3K |
| 80053 | Comprehensive metabolic panel | 80 | 80 | $2K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 13 | 13 | $2K |
| J3490 | Unclassified drugs | 16 | 12 | $136.50 |